
|Videos|April 9, 2021
Treatment considerations in node-positive prostate cancer
Author(s)Urology Times staff
Jason Zhu, MD, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Advertisement
Jason Zhu, MD, a medical oncologist at Levine Cancer Institute, part of Atrium Health, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
4
Sarah Azari, MD, on early sexual health education for women with bladder cancer
5






